Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study

Fig. 2

Median Change in Weight From Double-Blind Baseline Through 6 Months of Open-Label Treatment With Lurasidone, by Treatment Assignment in the Double-Blind Study. LUR = lurasidone; RIS = risperidone. *Subgroup entering open-label extension; 6-month completer analysis: LUR-LUR, n = 109; RIS-LUR, n = 66. †Patients in the RIS-LUR group received risperidone in the 12-month, double-blind study

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us